Excitation of type II caudate neurons by systemic administration of dopamine agonists

Brain Research

Volumn 706, Issue 2, 1996, Pages 249-258

  Piercey, Montford F ^a   Hyslop, Deborah K ^a   Hoffmann, William E ^a  

^a PFIZER INC   (United States)

Author keywords

Dopamine receptor; Nigrostriatal; Parkinson's disease; Striatum; Substantia nigra

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; APOMORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELECTROPHYSIOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0030032537     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01151-X     Document Type: Article

References (55)

1. Aghajanian, G.K. and Bunney, B.S., Dopamine 'autoreceptors': Pharmacological characterization by microiontophoretic single cell recording studies, Arch. Pharmacol., 297 (1977) 1-7.
2. Baring, M.D., Walters, J.R. and Eng, N., Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion, Brain Res., 181 (1980) 214-218.
3. Bergstrom, D.A., Bromley, S.D. and Walters, J.R., Apomorphine increases the activity of rat globus pallidus neurons, Brain Res., 238 (1982) 266-271.
4. Bergstrom, D.A., Bromley, S.D. and Walters, J.R., Dopamine agonists increase pallidal unit activity: Attenuation by agonist pretreatment and anesthesia, Eur. J. Pharmacol., 100 (1984) 3-12.
5. 3H] dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists, J. Pharmacol. Exp. Ther., 241 (1987) 27-33.
6. Bunney, B.S. and Aghajanian, G.K., d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway, Naunyn-Schmiedeberg's Arch. Pharmacol., 304 (1978) 255-261.
7. Bunney, B.S., Aghajanian, G.K. and Roth, R.H., Comparison of effects of L-DOPA, amphetamine and apomorphine on firing rates of rat dopaminergic neurons, Nature, 245 (1973) 123-125.
8. Bunney, B.S., Walters, J.R., Roth, R.H. and Aghajanian, G.K., Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity, J. Pharmacol. Exp. Ther., 185 (1973) 560-571.
9. Carlson, J.H., Bergstrom, D.A. and Walters, J.R., Neurophysiological evidence that D-1 dopamine receptor blockade attenuates post-synaptic but not autoreceptor-mediated effects of dopamine agonists, Eur. J. Pharmacol., 21 (1986) 237-251.
10. 2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: A neurophysiological study, Brain Res., 400 (1987) 205-218.
11. Carlsson, A., Fuxe, K., Hamberger, B. and Lindqvist, M., Biochemical and histochemical studies on the effects of imipramine-like drugs and d-amphetamine on central and peripheral catecholamine neurons, Acta Physiol. Scand., 67 (1966) 481-497.
12. Carlsson, A. and Lindqvist, M., Effect of chlorpromazine or haloperidol on formation of 3-methoxy-tyramine and normetanephrine in mouse brain, Acta Pharmacol., 20 (1963) 140-144.
13. Chieuh, C.C. and Moore, K.E., Relative potencies of D-and L-amphetamine on the release of dopamine from cat brain in vivo, Res. Commun. Chem. Path. Pharmacol., 7 (1974) 189-199.
14. Civelli, O., Buznow, J.R. and Grandy, K.D., Molecular diversity of the dopamine receptors, Annu. Rev. Pharmacol. Toxicol., 32 (1993) 281-307.
15. Costa, E., Gropetti, A. and Naimzada, M.K., Effect of amphetamine on the turnover rate of brain catecholamines and motor activity, Br. J. Pharmacol., 44 (1972) 742-751.
16. Crossman, A.R., Walker, R.J. and Woodruff, G.N., Problems associated with iontophoretic studies in the caudate nucleus and substantia nigra, Neuropharmacology, 13 (1974) 547-552.
17. Curtis, D.R., Microelectrophoresis. In W.L. Natuk (Ed.), Physical Techniques in Biological Research, Volume V, Electrophysiological Methods, Academic Press, NY, 1964, pp. 144-190.
18. Ferris, R.M., Tang, F.L.M. and Maxwell, R.A., A comparison of the capacities of isomers of amphetamine, deoxypiperidine and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus, and striatum and into adrenergic nerves of rabbit aorta, J. Pharmacol. Exp. Ther., 181 (1972) 407-416.
19. Ganon, F.G. and Buda, M.J., Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum, Neuroscience, 14 (1985) 765-774.
20. Haracz, J.L., Tschanz, J.T., Greenberg, J. and Rebec, G.V., Amphetamine-induced excitations predominate in single neurons showing motor-related activity, Brain Res., 489 (1989) 363-368.
21. Hu, X.-T., Wachtel, S.R., Galloway, M.P. and White, F.J., Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation, J. Neurosci., 10 (1990) 2318-2329.
22. Hu, X.-T. and Wang, R.Y., Comparison of the effects of D1 and D2 dopamine receptor agonists on neurons in the rat caudate putamen: An electrophysiological study, J. Neurosci., 8 (1988) 4340-4348.
23. Hyslop, D.K., Hoffmann, W.E., Smith, M.W. and Piercey, M.F., Excitation of anterior caudate neurons by stimulation of D3 receptors, Neurosci. Abstr., 19 (1993) 80.
24. Johnson, S.W., Hoffer, B.J. and Freedman, R., Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate, J. Neurosci., 6 (1986) 572-580.
25. Lahti, R.A., Figur, L.M., Piercey, M.F., Ruppel, P.L. and Evans, D.L., Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: Utilization of receptor state binding affinities, Mol Pharmacol., 42 (1992) 432-438.
26. 3 dopamine receptors in rat brain and pituitary gland: A quantitative autoradiographic study, J. Pharmacol. Exp. Ther., 264 (1993) 991-1001.
27. 2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons, Eur. J. Pharmacol., 200 (1991) 103-112.
28. Meller, E., Helmer-Matyjek, E., Bohmaker, K., Adler, C. H., Friedhoff, A.J. and Goldstein, M., Receptor reserve at striatal dopamine autoreceptors: Implications for selectivity of dopamine agonists, Eur. J. Pharmacol., 123 (1986) 311-314.
29. Napier, T.C., Simpson, P.E. and Givens, B.S., Dopamine electrophysiology of ventral pallidal-substantia innominata neurons: Comparison with the dorsal globus pallidus, J. Pharmacol. Exp. Ther., 258 (1991) 249-262.
30. Norcross, K. and Spehlmann, R., Selective blockade of excitatory caudate responses to nigral stimulation by microiontophoretic application of dopamine antagonists, Neurosci. Lett., 6 (1977) 323-328.
31. O'Connor, J.D., Caudate nucleus neurones: Correlation of the effects of substantia nigra stimulation with iontophoretic dopamine, J. Physiol., 208 (1970) 691-703.
32. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd Edn., Academic Press, FL, 1986.
33. Pierce, R.C. and Rebec, G.V., Iontophoresis in the neostriatum of awake, unrestrained rats: Differential effects of dopamine, glutamate, and ascorbate on motor-and nonmotor-related neurons, Neuroscience, (1995) in press.
34. Piercey, M.F., Hoffmann, W.E. and Vogelsang, G.D., Electrophysiological evaluation of a partial agonist-antagonist of dopamine receptors, J. Pharmacol. Exp. Ther., 243 (1987) 391-396.
35. Piercey, M.F., Broderick, P.A., Hoffmann, W.E. and Vogelsang, G.D., Effects of a potent autoreceptor agonist, U-68553B, on dopamine neuron firing rates and dopamine release, J. Pharmacol. Exp. Ther., 254 (1990) 369-374.
36. Pinnock, R.D., Sensitivity of compacta neurones in the rat substantia nigra slice to dopamine agonists, Eur. J. Pharmacol., 96 (1983) 269-276.
37. Rebec, G.V., Neuropharmacology of amphetamine: Changes in the activity of striatal neurons during behavior. In R.R. Watson (Ed.), Drugs of Abuse and Neurobiohgy, CRC Press, Boca Raton, FL, 1992, pp. 149-174.
38. Sasaki, K., Suda, H., Watanabe, H., Kaneko, S., Nomura, Y., Nishino, H. and Ono, T., Habenular lesion attenuates methamphetamine-induced inhibition of dopamine neuronal activity in the substantia nigra pars compacta of rats, Neurosci. Lett., 86 (1988) 67-71.
39. Setler, P.E., Sarau, H.M., Zircle, C.L. and Saunders, H.L., The central effects of a novel dopamine agonist, Eur. J. Pharmacol., 50 (1978) 419-430.
40. Siggens, G.R., Electrophysiological role of dopamine in striatum excitatory or inhibitory? In M.A. Lipton, A. DiMascio and K.F. Killam (Eds.), Psychopharmacology: A Generation of Progress, Raven Press, NY, 1978, pp. 143-157.
41. Siggens, G.R., Hoffer, B.J. and Ungerstedt, U., Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons, Life Sci., 15 (1974) 779-792.
42. Skirboll, L.R. and Bunney, B.S., The effects of acute and chronic haloperidol treatment on spontaneously firing neurons in the caudate nucleus of the rat, Life Sci., 25 (1979) 1419-1434.
43. Skirboll, L.R., Grace, A.A. and Bunney, B.S., Dopamine auto-and postsynaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists, Science, 206 (1979) 80-82.
44. 3) as a target for neuroleptics, Nature, 347 (1990) 146-151.
45. Titus, R.D., Kornfield, E.D., Jones, N.D., Clemens, J.A., Smalstig, E.B., Fuller, R.W., Hahn, R.A., Hynes, M.D., Mason, N.R., Wong, D.T. and Foreman, M.M., The resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H(or2H)-pyrazolo[3,4-g]quinoline, J. Med. Chem., 26 (1983) 1112-1116.
46. Tschanz, J.T., Griffith, K.E., Haracz, J.L. and Rebec, G.V., Cortical lesions attenuate the opposing effects of amphetamine and haloperidol on neostriatal neurons in freely moving rats, Eur. J. Pharmacol., 257 (1994) 161-167.
47. Vogelsang, G.D. and Piercey, M.F., The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol, Eur. J. Pharmacol., 110 (1985) 267-269.
48. VonVoigtlander, P.F. and Moore, K.E., Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine, J. Pharmacol. Exp. Ther., 184 (1973) 542-552.
49. Walters, J.R., Bergstrom, D.A. and Carlson, J.H., Effects of D-1 and D-2 receptor stimulation on single unit activity in the substantia nigra and globus pallidus. In G.N. Woodruff (Ed.), Dopamine Systems and their Regulation, MacMillan, London, 1986, pp. 63-78.
50. 2 agonist effects, Science, 236 (1987) 719-722.
51. Walters, J.R. and Roth, R.H., Dopaminergic neurons: Drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow, J. Pharmacol. Exp. Ther., 191 (1974) 82-91.
52. Warenycia, M.W. and McKenzie, G.M., Excitation of striatal neurons by dexamphetamine is not abolished by either chloral hydrate or urethane anesthesia, Neuropharmacology, 27 (1988) 1309-1312.
53. White, F.J. and Wang, R.Y., Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: Microiontophoretic studies, J. Pharmacol Exp. Ther., 231 (1984) 275-280.
54. White, F.J. and Wang, R.Y., Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens, J. Neurosci., 6 (1986) 274-280.
55. York, D.H., The inhibitory actions of dopamine on neurones of the caudate nucleus, Brain Res., 5 (1967) 263-266.